Cosmo Pharmaceuticals N.V. (LON:0RGI)

Market Cap	1.23B +65.7%
Revenue (ttm)	90.88M -61.0%
Net Income	-3.15M
EPS	-0.20
Shares Out	n/a
PE Ratio	n/a
Forward PE	873.45
Dividend	1.73 (2.19%)
Ex-Dividend Date	Jun 4, 2025

Volume	2,297
Average Volume	9,346
Open	82.00
Previous Close	79.99
Day's Range	80.20 - 82.00
52-Week Range	41.65 - 129.60
Beta	1.44
RSI	28.69
Earnings Date	Mar 9, 2026

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cor...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1997
• Employees: 325
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RGI

Financial Performance

Financial numbers in EUR